Uncategorized
Good results seen with single-use combination solution for intracameral mydriasis, anesthesia
MAASTRICHT, Netherlands — Mydrane, the first commercially launched intracameral mydriatic and anesthetic combination, proved effective and reliable in a study presented at the European Society of Cataract and Refractive Surgeons winter meeting. Mydrane (Laboratoires Théa) is prepared into single-use vials containing a combination of 0.02% tropicamide, 0.31% phenylephrine and 1% lidocaine, and it comes in boxes of 20 vials.